G6PD Deficiency and Induced Hemolysis

Slides:



Advertisements
Similar presentations
Glucose 6-phosphate dehydrogenase deficiency
Advertisements

Pentose Phosphate Pathway Generation of NADPH and Pentoses COURSE TITLE: BIOCHEMISTRY 2 COURSE CODE: BCHT 202 PLACEMENT/YEAR/LEVEL: 2nd Year/Level 4, 2nd.
Enzymopathies = ENZYME DEFECTS
Research Methodology of Biotechnology: Protein-Protein Interactions Yao-Te Huang Aug 16, 2011.
CISC667, F05, Lec24, Liao1 CISC 667 Intro to Bioinformatics (Fall 2005) DNA Microarray, 2d gel, MSMS, yeast 2-hybrid.
Chapter 6 Metabolism: Energy and Enzymes. Metabolism The totality of an organism's chemical reactions, consisting of catabolic and anabolic pathways Catabolic.
Pentose Phosphate Pathway Generation of NADPH and Pentoses.
Comparative Genomics of the Eukaryotes
Nibrin & Nijmegen breakage syndrome Nicole LibertApril 23, 2015.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY
Dr. Saidunnisa, MD Professor of Biochemistry
Metabolic Pathways  Linked reactions, one reaction leads to another  Enzyme – organic catalyst (speeds chemical reaction)  Ribozymes – made of RNA,
PENTOSE PHOSPHATE SHUNT or HEXOSE MONOPHOSPHATE PATHWAY This pathway consists of two parts: 1) Glucose-6-P undergoes two oxidations by NADP +, the second.
Chapters 19 - Genetic Analysis of Development: Development Development refers to interaction of then genome with the cytoplasm and external environment.
TCA & Pentose Phosphate Pathway 12/01/2009. Citrate Synthase.
The hexose monophosphate shunt: Overview © Michael Palmer 2014.
Case Study #1 You are an Army officer during the Korean War, and are in charge of a group of soldiers preparing to deploy from Fort Dix, New Jersey. In.
Glucose -6-phosphate dehydrogenase deficiency
Case Study 1: G6PD David Grkovicious Andrew Wattals Tim Cryal.
Glucose-6-Phosphate Dehydrogenase
GLUCOSE-6-PHOSPATE DEHYDROGENASE DEFICIENCY GENETICS PRESENTATION BY GROUP A2(MD2) WINDSOR UNIVERSITY SCHOOL OF MEDICINE. IVEREN,FOLA,FLOURISH, ALLISON,
The Citric Acid Cycle and the Pentose Phosphate Pathway.
Glucose-6-Phosphate Dehydrogenase
Glucose 6-phosphate dehydrogenase deficiency HMIM224.
Mary-Kayt Jones Genetics 564 Spring 2014
Mader: Biology 8 th Ed. Metabolism: Energy and Enzymes Chapter 6.
Chapters 19 - Genetic Analysis of Development:
Biological Networks. Can a biologist fix a radio? Lazebnik, Cancer Cell, 2002.
Glucose-6-Phosphate Dehydrogenase
Fanconi Anemia Anthony Winchell. What is Fanconi Anemia?
Overviw Red cell enzyme Red cell enzyme Glucose-6-phosphate dehydrogenase deficiency Glucose-6-phosphate dehydrogenase deficiency Causes: Causes: Symptoms.
Lab 9 G6PD Daheeya AlEnazi.
Alzheimer’s Disease and the influence of Presenilin 1
Prader Willi Syndrome & Necdin
By: Holly Heacock Prader Willi Syndrome & Necdin.
The Code of Life: Topic 4 Regulation of gene expression.
Genetic Basis of Embryonic Development
Bonus #2 due 4/21 Inheritance.
5 Microbial Metabolism.
Glucose-6-PhosphateDehydrogenase Deficiency Glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most frequent disease involving enzymes of the.
Pentose Phosphate Pathway
Genetic Disorders.
Von Hippel-Lindau Disease
Enzymes Regulatory enzymes are usually the enzymes that are the rate-limiting, or committed step, in a pathway, meaning that after this step a particular.
Pentose Phosphate Pathway
PENTOSE PHOSPHATE SHUNT or HEXOSE MONOPHOSPHATE PATHWAY
Chapters 19 - Genetic Analysis of Development:
Glucose-6-Phosphate Dehydrogenase
The hexose monophosphate shunt
Relationship between Genotype and Phenotype
OBJECTIVES To understand the function of the pentose phosphate pathway in production of NADPH and ribose precursors for nucleic acid synthesis. To examine.
Regulation of Gene Expression
Pentose phosphate pathway (PPP or HMPP)
Volume 9, Issue 8, Pages (August 2016)
4.3 Electron Transport Chain
Protein Complex Discovery
General idea and concepts of cell-cell signaling
Review Warm-Up What is the Central Dogma?
Unit III Information Essential to Life Processes
Chapters 19 - Genetic Analysis of Development:
Relationship between Genotype and Phenotype
Pharmacology 3 antimalarial drugs lecture 11 by Prof.Dr. Mohamed Fahmy
Protein Complex Discovery
Discovery of Unconventional Kinetochores in Kinetoplastids
Approach to Haemolysis
Pentose phosphate pathway (hexose monophosphate shunt)
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency
Relationship between Genotype and Phenotype
4.3 Electron Transport Chain
Glucose-6-phosphate dehydrogenase deficiency: a historical perspective
Presentation transcript:

G6PD Deficiency and Induced Hemolysis Diane Xue

Red blood cells burst due to oxidative stress What is Hemolysis? Red blood cells burst due to oxidative stress

How do Cells Become Oxygen-Stressed? G6PD G6PD No Build-up of Reactive Oxygen Species G6PD deficiency  Build-up of reactive oxygen species

What is the function of normal G6PD?  NAD binding domain C-terminal domain X Cellular Component Cytoplasm Molecular Functions NADP Binding Biological Process NADP Metabolism

How well conserved is G6PD?  NAD binding domain C-terminal domain 65- 240 Humans 35-210 Mouse 43-218 Zebrafish 242-540 212-510 220-518 39-214 Fruit fly 216-515 37-216 C. elegans 218-518 15-196 Yeast 198-494 35-221 Arabidopsis 223-510

Which G6PD mutations cause deficient G6PD Protein? Over 200 G6PD deficiency mutations have been sequenced

What Proteins Interact with G6PD? NADP METABOLISM

How is hemolysis triggered in G6PD-deficient cells? External factors such as the antimalarial Primaquine

Can G6PD be upregulated? ** THIS STUDY WAS ONLY DONE ON MALES

Goal: How does G6PD Methylation affect G6PD levels in Pregnant Females?  NAD binding domain C-terminal domain

How does G6PD Methylation affect G6PD levels in Pregnant Females? Aim 1: Knockout conserved methylation sites of G6PD to identify methylation sites associated with normal levels of NADPH production in pregnant females. Aim 2: Identify a small molecule that affects methylation of G6PD and can be taken with Primaquine in pregnant females Aim 3 Determine differences in protein interaction complexes required for NADP metabolism between methylated and unmethylated G6PD deficient pregnant zebrafish Bisulfite DNA-Seq Chemical Screen Fluorescent Spot Test Bisulfite DNA-Seq ClustalOmega CRISPR Fluorescent Spot Test CRISPR Affinity pulldown Mass Spectrometry

What Model Organism Will I Use? Short generation times Inexpensive g6pd deficiency phenotype similar to Humans Transparency allows visualization of hemolysis

Aim 1: Identify conserved methylation sites in G6PD normal pregnant zebrafish Stage 1: Bisulfite-sequencing Compare the methylation pattern in male, non-pregnant female, and pregnant zebrafish with normal and abnormal levels of NADPH: P  NAD binding domain C-terminal domain

Aim 1: Identify conserved methylation sites in G6PD normal pregnant zebrafish Stage 2: ClustalOmega Determine if methylation sites are conserved across homologs:  NAD binding domain C-terminal domain

Aim 1: Identify conserved methylation sites in G6PD normal pregnant zebrafish Stage 3: CRISPR and Fluorescent Spot Test Knockout the most conserved methylation sites using CRISPR. Then, determine levels of NADP reduction using Fluorescent Spot Test  NAD binding domain C-terminal domain NADPH is naturally fluorescent

Aim 2: Identify a small molecule that affects G6PD methylation Stage 1: Bisulfite Sequencing Determine the methylation pattern in G6PD deficient pregnant zebrafish P  NAD binding domain C-terminal domain

Aim 2: Identify a small molecule that affects G6PD methylation Stage 2: Chemical Screen Identify a small molecule that affects DNA methylation, destroys malaria parasite, and can be taken with Primaquine without causing hemolysis in G6PD deficient pregnant zebrafish.

Aim 2: Identify a small molecule that affects G6PD methylation Stage 3: Fluorescent Spot Test and Bisulfite Sequencing II Analyze NADPH levels and methylation changes  NAD binding domain C-terminal domain

Aim 3: Determine differences in Protein-complexes associated with methylation changes Stage 1: CRISPR Knockout the conserved methylation sites of pregnant females using CRISPR  NAD binding domain C-terminal domain Control  NAD binding domain C-terminal domain Treatment

Aim 3: Determine differences in Protein-complexes associated with methylation changes Stage 2: Tandem Affinity Purification and Pull Down

Aim 3: Determine differences in Protein-complexes associated with methylation changes Stage 3: Mass Spectrometry

References http://soliris.net/resources/images/consq-hemolysis-bg.jpg https://openi.nlm.nih.gov/detailedresult.php?img=PMC2715191_omcl0101_0015_fig001&req=4 http://intranet.tdmu.edu.ua/data/kafedra/internal/chemistry/classes_stud/en/stomat/ptn/2/03.%20introduction%20to%20 %20metabolism.%20investigation%20of%20aerobic%20and%20anaerobic%20oxidation%20of%20glucose.htm http://geneticsandpublichealth.com/2016/06/05/glucose-6-phosphate-dehydrogenase-deficiency/ https://www.thediabetescouncil.com/diabetes-and-anemia-are-they-related/ https://www.researchgate.net/publication/236088554_Review_of_key_knowledge_gaps_in_glucose-6- phosphate_dehydrogenase_deficiency_detection_with_regard_to_the_safe_clinical_deployment_of_8- aminoquinoline_treatment_regimens_A_workshop_report